CareCloud announces results from annual meeting
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 28 2025
0mins
Should l Buy CCLD?
Shareholder Meeting Outcomes: CareCloud held its 2025 Annual Shareholders' Meeting on May 27, where shareholders re-elected Anne Busquet, Bill Korn, and Lawrence Sharnak for another two-year term.
Approval of Proposals: Shareholders approved the advisory compensation of named executive officers and appointed Rosenberg Rich Baker Berman, P.A. as the independent registered public accounting firm for the year ending December 31, 2025.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CCLD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CCLD
Wall Street analysts forecast CCLD stock price to rise
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 3.520
Low
3.25
Averages
6.42
High
8.00
Current: 3.520
Low
3.25
Averages
6.42
High
8.00
About CCLD
CareCloud, Inc. is a provider of technology-enabled services and generative artificial intelligence (AI) solutions that redefine the healthcare revenue cycle management process. It provides technology-enabled revenue cycle management and a full suite of proprietary cloud-based solutions to healthcare providers, from small practices to enterprise medical groups, hospitals, and health systems throughout the United States. Its Healthcare IT segment includes technology-assisted revenue cycle management, software-as-a-service solutions and professional and other services. Its Medical Practice Management segment includes the management of three medical practices. Its technology-enabled business solutions include Technology-enabled revenue cycle management, Cloud-based software, Digital health, and Healthcare IT professional services & staffing. Its revenue cycle management services, including end-to-end medical billing, eligibility, analytics, and related services.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

- Incident Cause: The incident was attributed to an unauthorized third party who temporarily gained access to the system.
- Security Implications: This breach raises concerns about the security measures in place to protect sensitive information.
See More

Network Disruption: A significant disruption occurred in the CareCloud Health Division on March 16, 2026, impacting operations and services.
SEC Filing: The incident has prompted the company to file a report with the Securities and Exchange Commission (SEC) regarding the network issues.
See More
- Significant Profit Growth: CareCloud reported a profit of $1.52 million in Q4, a substantial increase from $0.01 million in the same period last year, indicating strong performance and improved profitability in the market.
- Improved EPS: The earnings per share for Q4 reached $0.04, compared to $0.00 in the same period last year, demonstrating a notable advancement in the company's profitability and boosting investor confidence.
- Strong Adjusted Earnings: Excluding items, CareCloud reported adjusted earnings of $4.46 million or $0.11 per share, reflecting robust growth in the company's core business and an enhancement in earnings quality.
- Sustained Revenue Growth: Q4 revenue was $34.42 million, up 21.8% from $28.24 million in the same period last year, showcasing the company's ongoing expansion in customer base and market demand.
See More
- Earnings Performance: CareCloud reported a Q4 non-GAAP EPS of $0.07, missing expectations by $0.04, indicating pressure on profitability that may affect investor confidence.
- Revenue Growth: The company achieved Q4 revenue of $34.42 million, a 22.1% year-over-year increase, exceeding market expectations by $2.32 million, demonstrating strong demand in the healthcare IT sector.
- Fiscal Year 2026 Outlook: CareCloud projects FY 2026 revenue between $128 million and $132 million, with adjusted EBITDA expected to be between $29 million and $31 million, indicating future growth potential but raising concerns about profitability.
- EPS Guidance: The company anticipates GAAP EPS for FY 2026 to be between $0.20 and $0.23, and while revenue is growing, the lower end of the earnings forecast may raise market concerns regarding its long-term profitability.
See More
- Earnings Announcement: CareCloud (CCLD) is set to release its Q4 earnings report on March 12 before the market opens, drawing significant attention from investors regarding its performance.
- Earnings Expectations: The consensus EPS estimate stands at $0.04, reflecting an 83.3% year-over-year decline, indicating potential profitability challenges that could affect investor confidence.
- Revenue Forecast: The revenue estimate is projected at $32.1 million, representing a 13.8% year-over-year increase, suggesting the company maintains some resilience in revenue growth, which may attract long-term investors.
- Historical Performance: Over the past two years, CCLD has beaten EPS estimates 63% of the time and revenue estimates 75% of the time, demonstrating relative stability in financial forecasting that could reassure stakeholders.
See More






